C
TBPH icon

Chescapmanager’s Theravance Biopharma TBPH Stock Holding History

Chescapmanager’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-96,197
Closed -$816K – 40
2024
Q2 		$816K Sell
96,197
-105,168
-52% -$949K 0.07% 36
2024
Q1 		$1.81M Sell
201,365
-28,403
-12% -$263K 0.18% 36
2023
Q4 		$2.58M Sell
229,768
-57,565
-20% -$579K 0.25% 33
2023
Q3 		$2.48M Hold
287,333
– – 0.32% 36
2023
Q2 		$2.97M Sell
287,333
-335,405
-54% -$3.7M 0.46% 35
2023
Q1 		$6.76M Sell
622,738
-228,250
-27% -$2.41M 1.06% 27
2022
Q4 		$9.55M Sell
850,988
-309,515
-27% -$3.25M 2.24% 17
2022
Q3 		$11.8M Hold
1,160,503
– – 2.74% 14
2022
Q2 		$10.5M Sell
1,160,503
-6,071
-0.5% -$55.9K 2.48% 16
2022
Q1 		$11.2M Sell
1,166,574
-95,100
-8% -$932K 1.51% 21
2021
Q4 		$13.9M Sell
1,261,674
-630,778
-33% -$5.5M 1.86% 25
2021
Q3 		$14M Buy
1,892,452
+630,734
+50% +$7.05M 1.98% 20
2021
Q2 		$18.3M Buy
1,261,718
+127,000
+11% +$2.38M 2.01% 20
2021
Q1 		$23.2M Hold
1,134,718
– – 2.47% 13
2020
Q4 		$20.2M Sell
1,134,718
-23,000
-2% -$413K 2.46% 12
2020
Q3 		$17.1M Buy
1,157,718
+60,000
+5% +$1.12M 2.77% 12
2020
Q2 		$23M Buy
1,097,718
+95,000
+9% +$2.44M 3.88% 8
2020
Q1 		$23.2M Buy
1,002,718
+53,712
+6% +$1.34M 5.67% 5
2019
Q4 		$24.6M Buy
949,006
+351,422
+59% +$6.83M 3.61% 8
2019
Q3 		$11.6M Buy
597,584
+48,835
+9% +$987K 1.66% 17
2019
Q2 		$8.96M Buy
548,749
+99,885
+22% +$2.02M 0.89% 26
2019
Q1 		$10.2M Buy
448,864
+33,943
+8% +$861K 1.21% 23
2018
Q4 		$10.6M Buy
414,921
+6,000
+1% +$162K 2.56% 16
2018
Q3 		$13.4M Buy
408,921
+5,600
+1% +$153K 1.37% 26
2018
Q2 		$9.15M Buy
403,321
+52,690
+15% +$1.25M 1.06% 29
2018
Q1 		$8.5M Buy
350,631
+57,614
+20% +$1.58M 1.27% 27
2017
Q4 		$8.17M Buy
293,017
+11,480
+4% +$340K 1.33% 27
2017
Q3 		$9.64M Buy
281,537
+60,420
+27% +$1.98M 1.88% 23
2017
Q2 		$8.81M Buy
221,117
+1,814
+0.8% +$69.7K 1.49% 23
2017
Q1 		$8.07K Sell
219,303
-52,850
-19% -$1.69M 1.11% 24
2016
Q4 		$8.68M Buy
+272,153
New +$8.44M 3.18% 14

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Chescapmanager's TBPH Position: Q3 2024 in Review

Chescapmanager sold out of Theravance Biopharma (TBPH) in Q3 2024, closing a stake of 96,197 shares — an estimated $816K sold.

Chescapmanager first reported a position in TBPH in Q4 2016 and held it in 31 quarters. The position peaked at $24.6M in Q4 2019. 119 funds tracked by Wall St. Rank hold TBPH as of Q3 2024.

  • Chescapmanager reported no remaining Theravance Biopharma position as of Q3 2024 after selling out during the quarter.
  • Chescapmanager sold 96,197 Theravance Biopharma shares in Q3 2024, an estimated $816K.
  • Chescapmanager first reported a position in Theravance Biopharma in Q4 2016 and held it in 31 quarters.
  • Chescapmanager's Theravance Biopharma position peaked at $24.6M in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2024.

Based on Chescapmanager's 13F filing for Q3 2024, filed 14 Nov 2024.